IL22 and stomach disorder: Based on the in vitro data and the clinical observation in this study, IL-22 appears to play a beneficial and/or protective role in H. pylori-induced gastric diseases, preventing overproduction of inflammatory cytokines and maintaining the homeostasis of gastric immunity.